“Global Hypertension Drugs Market 2014-2018” report published at Reports and Intelligence
Portland, OR -- (ReleaseWire) -- 07/29/2014 --Hypertension, also referred as arterial hypertension or high BP, is a chronic medical condition in which the arterial blood pressure is elevated to an undesired level. Lifestyle habits such as diet, exercising, and smoking are the major causes of hypertension. Hypertension can damage organs and lead to several illnesses such as renal failure, aneurysm, heart failure, stroke, and heart attack. There are two types of hypertension: primary or essential and secondary.
TechNavio's analysts forecast the Global Hypertension Drugs market will grow at a CAGR of 1.2 percent over the period 2013-2018.
Get full report at: http://www.reportsandintelligence.com/global-hypertension-drugs-2014-2018-market
The Global Hypertension Drugs market can be categorized into eight segments: Diuretics, ACE Inhibitors, ARBs, CCB, Beta Blockers, Alpha Blockers, Vasodilators, and Renin Inhibitors. To calculate the market size, the report considers the revenue generated from the sales of various hypertension drugs used in the treatment of pulmonary arterial hypertension and essential hypertension.
For sample request visit at: http://www.reportsandintelligence.com/global-hypertension-drugs-2014-2018-market/request-sample
TechNavio's report, the Global Hypertension Drugs Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Hypertension Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.